Comparison of quantitative HCV RNA assays in chronic hepatitis C

American Journal of Clinical Pathology

Volumn 107, Issue 3, 1997, Pages 362-367

  Jacob, Sheraj ^a   Baudy, Deborah ^a   Jones, Elizabeth ^a   Xu, Lizhe ^a   Mason, Andrew ^a   Regenstein, Fredric ^a   Perrillo, Robert P ^a,b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b NONE   (United States)

Author keywords

Hepatitis C virus; hepatitis C virus genotypes; quantitative RNA; RNA

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ARTICLE; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VIREMIA; VIRUS DETECTION; VIRUS STRAIN;

EID: 0031040110     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.3.362     Document Type: Article

References (27)

1. Choo QL, Kiro G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science. 1989;244:1-3.
2. Choo QL, Weiner AJ, Overby LR, et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull. 1990;46:423-441.
3. Kubo Y, Takeuchi K, Boonmar S, et al. A cDNA fragment of hepatitis C virus isolated from an implicated donor of post transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res. 1989;17:10367-10372.
4. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991;88:2451-2455.
5. Takamizava A, Mori C, Fuke I, et al. Structure and organisation of the hepatitis C virus genome isolated from human carriers. J Virol. 1991;65:1105-1113.
6. Nakao T, Enomoto N, Takada N, Takada A, Dati T. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol. 1991;72:2105-2112.
7. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19:1321-1324.
8. Lau JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 1993;341:1501-1504.
9. Hayashi J, Ohmiya M, Kishihara N, et al. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol. 1994;89:2151-2156.
10. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with hepatitis C. Dig Dis Sci. 1994;39:1273-1280.
11. Mita E, Hayashi N, Hagiwara H, , et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci. 1994;39:977-982.
12. Magrin S, Craxi A, Fabiano C, et al. Serum hepatitis C virus (HCV)-RNA and response to alpha interferon in anti HCV positive chronic hepatitis. J Med Virol. 1992;38:200-206.
13. Pozzato G, Kaneko S, Morretti M, et al. Different genotypes of hepatitis C virus are associated with different severity of liver disease. J Med Virol. 1994;43:291-296.
14. Brechot C. Polymerase chain reaction: a new tool for the study of viral infections in hepatology. J Hepatol. 1990;11:124-129.
15. Lin HJ, Hollinger FB, Mizokami M, Shi N. A polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pair. J Med Virol. 1992;3:220-225.
16. Sanchez-Pescador R, Sheridan PJ, Detmer JJ, et al. Quantitative detection of HCV RNA sera using a chemiluminescent signal amplification oligonucleotide probe assay. Hepatology. 1992;16:588. Abstract.
17. Urdea MS, Horn T, Fultz TJ, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Res. 1991;24:197-200.
18. Zaaijier HL, Cuypers HT, Reesnik WH, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993;341:722-724.
19. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs and drug users. Lancet. 1990;336:1469-1472.
20. Detmer J, Lagier R, Flynn J, et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol. 1996;34:901-907.
21. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 1993;74:1093-1102.
22. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative study. J Clin Microbiol. 1994;32:884-892.
23. Davis GL. Predictors of response to interferon treatment of chronic hepatitis C. J Hepatol. 1994;21:1-3.
24. Lau JYN, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis. 1995;171:281-289.
25. Dusheiko G. Genetic diversity of hepatitis C virus: implications for pathogenesis, treatment, and prevention. Lancet. 1995;345:562-566.
26. Collins ML, Zayati C, Detmer JJ, et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem. 1995;226:120-129.
27. Roth KW, Lee JH, Ruster B, Zeuzem S. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol. 1996;34:261-264.